Tonix Pharmaceuticals, Inc.
509 Madison Ave.
Suite 306
New York
New York
10022
United States
Tel: 212-980-9155
Fax: 212-923-5700
Website: http://www.tonixpharma.com/
309 articles with Tonix Pharmaceuticals, Inc.
-
TONIX Pharmaceuticals, Inc. to Present at Biotech Showcase and OneMedForum Conferences in San Francisco on January 9 and 10, 2012
1/4/2012
-
TONIX Pharmaceuticals, Inc. to Present at the New York Society of Security Analysts' 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011
11/21/2011
-
TONIX Pharmaceuticals, Inc. Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 for Fibromyalgia
11/18/2011
-
TONIX Pharmaceuticals, Inc. and Tamandare Explorations Announce Completion of Share Exchange Transaction and Private Placement
10/14/2011
-
TONIX Pharmaceuticals, Inc.' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology
9/7/2011
-
TONIX Pharmaceuticals, Inc. Elects Charles Mather to Its Board of Directors
8/17/2011
-
TONIX Pharmaceuticals, Inc. Elects Harvey Moldofsky, M.D., to Its Scientific Advisory Board
6/20/2011
-
TONIX Pharmaceuticals, Inc. Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome
6/16/2011
-
TONIX Pharmaceuticals, Inc. to Present at the OneMedForum San Francisco 2011 on January 11 and at the Biotech Showcase on January 12
1/4/2011